Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Apr;24(1):167–173. doi: 10.1128/iai.24.1.167-173.1979

Effect of Type-Specific Active Immunization on the Development and Progression of Experimental Pseudomonas aeruginosa Endocarditis

Gordon L Archer 1, J Linda Johnston 1
PMCID: PMC414279  PMID: 110689

Abstract

Rabbits with intracardiac catheters were immunized with heat-killed Pseudomonas aeruginosa or saline and challenged with either 109 (high inoculum) or 107 (low inoculum) pseudomonas. Immunization did not decrease the incidence of endocarditis when compared with controls, but it did significantly prolong survival. The longer survival of immunized rabbits after high-inoculum challenge was not due to prolongation of the course of endocarditis but to type-specific protection from early, overwhelming bacteremia. However, after low-inoculum challenge there were no early deaths and there was a significantly (P < 0.01) longer survival of immunized (17.4 days) than unimmunized (10.6 days) animals dying of endocarditis. Increased survival was associated with higher total and 2-mercaptoethanol-resistant hemagglutinating antibody titers 1 week after challenge in immunized as compared with unimmunized rabbits. Early (48 h after challenge) vegetation colonization was also significantly (P < 0.05) greater after type-specific as opposed to non-type-specific or saline immunization and low-inoculum challenge. However, whereas 67% of type-specifically immunized rabbits had colonized vegetations at 48 h, only 38.9% died with bacteremic endocarditis. Another 19.2% of immunized rabbits had vegetations colonized with > 105 colony-forming units of pseudomonas at elective sacrifice 2 weeks after challenge but no bacteremia; no unimmunized rabbit exhibited similar late colonization. Preexisting antibody may be important in the pathogenesis of pseudomonas endocarditis in drug addicts, and its presence may explain the subacute and often protracted course of the disease.

Full text

PDF
167

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Archer G., Fekety F. R. Experimental endocarditis due to Pseudomonas aeruginosa. I. Description of a model. J Infect Dis. 1976 Jul;134(1):1–7. doi: 10.1093/infdis/134.1.1. [DOI] [PubMed] [Google Scholar]
  2. Archer G., Fekety F. R., Jr Experimental endocarditis due to Pseudomonas aeruginosa. II. Therapy with carbenicillin and gentamicin. J Infect Dis. 1977 Sep;136(3):327–335. doi: 10.1093/infdis/136.3.327. [DOI] [PubMed] [Google Scholar]
  3. Archer G., Fekety F. R., Supena R. Pseudomonas aeruginosa endocarditis in drug addicts. Am Heart J. 1974 Nov;88(5):570–578. doi: 10.1016/0002-8703(74)90240-3. [DOI] [PubMed] [Google Scholar]
  4. Crowder J. G., Devlin H. B., Fisher M., White A. Heat-stable opsonins in sera of patients with Pseudomonas infections. J Lab Clin Med. 1974 Jun;83(6):853–859. [PubMed] [Google Scholar]
  5. Crowder J. G., Fisher M. W., White A. Type-specific immunity in pseudomonas diseases. J Lab Clin Med. 1972 Jan;79(1):47–54. [PubMed] [Google Scholar]
  6. FELLER I., VIAL A. B., CALLAHAN W., WALDYKE J. USE OF VACCINE AND HYPERIMMUNE SERUM FOR PROTECTION AGAINST PSEUDOMONAS SEPTICEMIA. J Trauma. 1964 Jul;4:451–456. doi: 10.1097/00005373-196407000-00002. [DOI] [PubMed] [Google Scholar]
  7. Harvath L., Andersen B. R., Amirault H. J. Passive immunity against pseudomonas sepsis during granulocytopenia. Infect Immun. 1976 Nov;14(5):1151–1155. doi: 10.1128/iai.14.5.1151-1155.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Harvath L., Andersen B. R. Evaluation of type-specific and non-type-specific pseudomonas vaccine for treatment of pseudomonas sepsis during granulocytopenia. Infect Immun. 1976 Apr;13(4):1139–1143. doi: 10.1128/iai.13.4.1139-1143.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McGEOWN M. G. Bacterial endocarditis; an experimental study of healing. J Pathol Bacteriol. 1954 Jan;67(1):179–186. doi: 10.1002/path.1700670122. [DOI] [PubMed] [Google Scholar]
  10. Reyes M. P., Fisher M. W., Lerner A. M. Pseudomonas endocarditis: hemagglutinating antibodies to Fisher-Devlin-Gnabasik immunotypes in sera. J Lab Clin Med. 1974 Jun;83(6):845–852. [PubMed] [Google Scholar]
  11. Weinstein L., Schlesinger J. J. Pathoanatomic, pathophysiologic and clinical correlations in endocarditis (first of two parts). N Engl J Med. 1974 Oct 17;291(16):832–837. doi: 10.1056/NEJM197410172911609. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES